TR200000726T2 - Budesonid ve formoterol'ün yeni kullanımı. - Google Patents

Budesonid ve formoterol'ün yeni kullanımı.

Info

Publication number: TR200000726T2
Authority: TR; Turkey
Prior art keywords: formoterol; budesonide; new use; bulus; treatment
Prior art date: 1997-09-19

Application number

TR2000/00726T

Other languages

English (en)

Turkish (tr)

Inventor

Bauer Carl-Axel

Trofast Jan

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-09-19

Filing date

1998-09-09

Publication date

2000-09-21

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20408325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TR200000726(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1998-09-09 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2000-09-21 Publication of TR200000726T2 publication Critical patent/TR200000726T2/xx

Links

VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 title 1
229960004436 budesonide Drugs 0.000 title 1
BPZSYCZIITTYBL-UHFFFAOYSA-N formoterol Chemical compound C1=CC(OC)=CC=C1CC(C)NCC(O)C1=CC=C(O)C(NC=O)=C1 BPZSYCZIITTYBL-UHFFFAOYSA-N 0.000 title 1
229960002848 formoterol Drugs 0.000 title 1
208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
229940021598 formoterol and budesonide Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

TR2000/00726T 1997-09-19 1998-09-09 Budesonid ve formoterol'ün yeni kullanımı. TR200000726T2 (tr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
SE9703407A SE9703407D0 (sv)	1997-09-19	1997-09-19	New use

Publications (1)

Publication Number	Publication Date
TR200000726T2 true TR200000726T2 (tr)	2000-09-21

Family

ID=20408325

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TR2000/00726T TR200000726T2 (tr)	1997-09-19	1998-09-09	Budesonid ve formoterol'ün yeni kullanımı.

Country Status (38)

Country	Link
US (2)	US7897646B2 (cs)
EP (2)	EP1210943B1 (cs)
JP (1)	JP2001517630A (cs)
KR (1)	KR20010024140A (cs)
CN (1)	CN1149998C (cs)
AR (1)	AR013506A1 (cs)
AT (2)	ATE329599T1 (cs)
AU (1)	AU757235B2 (cs)
BR (1)	BR9812325A (cs)
CA (1)	CA2302700C (cs)
CY (1)	CY1106156T1 (cs)
CZ (1)	CZ295250B6 (cs)
DE (2)	DE69807239T2 (cs)
DK (2)	DK1210943T3 (cs)
EE (1)	EE04297B1 (cs)
ES (2)	ES2182357T3 (cs)
HK (1)	HK1045812B (cs)
HU (1)	HUP0003848A2 (cs)
ID (1)	ID24838A (cs)
IL (1)	IL134773A (cs)
IN (1)	IN190791B (cs)
IS (1)	IS2715B (cs)
MX (1)	MXPA00002615A (cs)
MY (1)	MY127812A (cs)
NO (1)	NO327176B1 (cs)
NZ (1)	NZ503173A (cs)
PL (1)	PL190782B1 (cs)
PT (2)	PT1014993E (cs)
RU (1)	RU2199322C2 (cs)
SA (1)	SA98190773B1 (cs)
SE (1)	SE9703407D0 (cs)
SI (2)	SI1014993T1 (cs)
SK (1)	SK285330B6 (cs)
TR (1)	TR200000726T2 (cs)
TW (1)	TW546140B (cs)
UA (1)	UA72446C2 (cs)
WO (1)	WO1999015182A1 (cs)
ZA (1)	ZA988516B (cs)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9703407D0 (sv)	1997-09-19	1997-09-19	Astra Ab	New use
SE9802073D0 (sv) *	1998-06-11	1998-06-11	Astra Ab	New use
CA2347856C (en) *	1998-11-13	2009-02-17	Jagotec Ag	Dry powder for inhalation
US6004537A (en) *	1998-12-18	1999-12-21	Baker Norton Pharmaceuticals, Inc.	Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
GB9928311D0 (en)	1999-11-30	2000-01-26	Novartis Ag	Organic compounds
GB0009584D0 (en) *	2000-04-18	2000-06-07	Glaxo Group Ltd	Pharmaceutical compositions
GB0012261D0 (en)	2000-05-19	2000-07-12	Astrazeneca Ab	Novel process
GB0012260D0 (en) *	2000-05-19	2000-07-12	Astrazeneca Ab	Novel composition
PL365736A1 (en) *	2001-02-06	2005-01-10	Innovata Biomed Limited	Bimodal dry powder formulation for inhalation
US20030055026A1 (en)	2001-04-17	2003-03-20	Dey L.P.	Formoterol/steroid bronchodilating compositions and methods of use thereof
US6667344B2 (en)	2001-04-17	2003-12-23	Dey, L.P.	Bronchodilating compositions and methods
SE0200312D0 (sv)	2002-02-01	2002-02-01	Astrazeneca Ab	Novel composition
CA2500065A1 (en) *	2002-09-30	2004-04-15	Acusphere, Inc.	Sustained release porous microparticles for inhalation
US6962006B2 (en) *	2002-12-19	2005-11-08	Acusphere, Inc.	Methods and apparatus for making particles using spray dryer and in-line jet mill
US20040121003A1 (en) *	2002-12-19	2004-06-24	Acusphere, Inc.	Methods for making pharmaceutical formulations comprising deagglomerated microparticles
TWI359675B (en)	2003-07-10	2012-03-11	Dey L P	Bronchodilating β-agonist compositions
ES2384641T3 (es)	2005-07-14	2012-07-10	Lithera, Inc.	Formulación lipolítica que potencia la liberación mantenida para el tratamiento localizado del tejido adiposo
CA2631492A1 (en) *	2005-12-15	2007-06-21	Acusphere, Inc.	Processes for making particle-based pharmaceutical formulations for oral administration
US7913223B2 (en) *	2005-12-16	2011-03-22	Dialogic Corporation	Method and system for development and use of a user-interface for operations, administration, maintenance and provisioning of a telecommunications system
GB0604141D0 (en) *	2006-03-01	2006-04-12	Arrow Int Ltd	Nebulizer formulation
PL2077830T3 (pl) *	2006-10-17	2013-04-30	Lithera Inc	Sposoby, kompozycje i formulacje do leczenia orbitopatii tarczycowej
US9132084B2 (en)	2009-05-27	2015-09-15	Neothetics, Inc.	Methods for administration and formulations for the treatment of regional adipose tissue
SI3106149T1 (sl)	2009-05-29	2020-07-31	Pearl Therapeutics, Inc.	Sestavki za pljučno dostavo muskarinskih antagonistov z dolgotrajnim delovanjem in agonistov beta-2 adrenergičnega receptorja z dolgotrajnim delovanjem in povezani postopki in sistemi
US8815258B2 (en)	2009-05-29	2014-08-26	Pearl Therapeutics, Inc.	Compositions, methods and systems for respiratory delivery of two or more active agents
WO2010144628A2 (en) *	2009-06-09	2010-12-16	Elevation Pharmaceuticals, Inc.	Treatment of chronic obstructive pulmonary disease with nebulized beta 2-agonist or combined nebulized beta 2-agonist and anticholinergic administration
CN102000090A (zh) *	2009-08-31	2011-04-06	北京利乐生制药科技有限公司	一种以布地奈德与阿福特罗为活性成分的复方制剂
BR112012017556A2 (pt) *	2010-01-15	2016-08-16	Lithera Inc	formulações de torta liofilizada
GEP201606551B (en)	2010-11-24	2016-10-10	Novamedica Llc	Selective, lipophilic, and long-acting beta agonists monotherapeutic formulations tions and methods for cosmetic treatment of adiposity and contour bulging
US9585930B2 (en)	2011-03-20	2017-03-07	Trustees Of Boston University	Therapeutic agent for emphysema and COPD
CN102362860A (zh) *	2011-10-27	2012-02-29	江阴长风医药科技有限公司	以氢氟烷烃为抛射剂的布地奈德和福莫特罗气雾剂制剂
HK1219059A1 (zh)	2013-03-15	2017-03-24	珍珠治疗公司	用於微粒晶体材料的状态调节的方法和系统
ITMI20130571A1 (it) *	2013-04-10	2014-10-11	Zambon Spa	Composizione farmaceutica contenente budesonide e formoterolo
WO2015065220A1 (ru) *	2013-10-28	2015-05-07	Шолекс Девелопмент Гмбх	Ингаляционный препарат для лечения бронхиальной астмы и хронической обструктивной болезни легких и способ его получения
GB201321712D0 (en)	2013-12-09	2014-01-22	Pharmachemie Bv	Dry Powder Inhaler
GB201321717D0 (en)	2013-12-09	2014-01-22	Pharmachemie Bv	Inhalable Medicaments
GB201408387D0 (en) *	2014-05-12	2014-06-25	Teva Pharmaceuticals Europ B V	Treatment of respiratory disorders
WO2017093758A1 (en)	2015-12-04	2017-06-08	Mexichem Fluor S.A. De C.V.	Pharmaceutical composition
JP7470646B2 (ja)	2018-06-14	2024-04-18	アストラゼネカ・ユーケイ・リミテッド	コルチコステロイド医薬組成物を用いて喘息の症状を治療および予防するための方法
WO2021048171A1 (en) *	2019-09-10	2021-03-18	INSERM (Institut National de la Santé et de la Recherche Médicale)	Method to improve phagocytosis
US12329759B2 (en)	2019-10-17	2025-06-17	Trustees Of Boston University	Methods and compositions relating to lung function

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0416950B1 (en)	1989-09-08	1993-08-11	Glaxo Group Limited	Medicaments
IL95590A (en)	1989-09-08	1996-06-18	Glaxo Group Ltd	Medicinal preparations containing Salmetrol and Pluticasone Propionate
US5250286A (en) *	1990-05-07	1993-10-05	Aegis Technology, Inc.	Treatment of chronic obstructive pulmonary disease (COPD) by inhalation of an imidazoline
PL164294B1 (pl)	1990-12-20	1994-07-29	Inst Farmaceutyczny	Sposób otrzymywania diastereoizomeru /22R/-16a , 17a-butylidenodioksy-11 ß 21-dihydroksy-1,4-pregnadien-3,20-dionu PL
US5795564A (en) *	1991-04-05	1998-08-18	Sepracor, Inc.	Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
US5444521A (en)	1991-07-15	1995-08-22	Canon Kabushiki Kaisha	Image fixing device capable of controlling heating overshoot
EP1086697A2 (en)	1991-12-18	2001-03-28	AstraZeneca AB	New combination of formoterol and budesonide
SK282826B6 (sk)	1991-12-18	2002-12-03	Aktiebolaget Astra	Farmaceutická kompozícia na podávanie inhaláciou s obsahom formoterolu a budesonidu a jej použitie
SE9404080L (sv) *	1993-12-28	1995-06-29	Ciba Geigy Ag	Förfarande för framställning av en optiskt ren enantiomer av formoterol
US5983956A (en) *	1994-10-03	1999-11-16	Astra Aktiebolag	Formulation for inhalation
SE9700134D0 (sv)	1997-01-20	1997-01-20	Astra Ab	New formulation
GB9519692D0 (en)	1995-09-27	1995-11-29	Quillin Helen	Atomising nozzle
ATE289994T1 (de) *	1995-11-24	2005-03-15	Glaxosmithkline Spa	Chinolin-derivate
SE9603669D0 (sv)	1996-10-08	1996-10-08	Astra Ab	New combination
SE9700135D0 (sv) *	1997-01-20	1997-01-20	Astra Ab	New formulation
ID24063A (id)	1997-06-27	2000-07-06	Astra Ab	Kombinasi obat anti asma
SE9703407D0 (sv) *	1997-09-19	1997-09-19	Astra Ab	New use
US6598603B1 (en) *	1997-12-31	2003-07-29	Astra Aktiebolag	Method for treating respiratory diseases
SE9802073D0 (sv)	1998-06-11	1998-06-11	Astra Ab	New use
DZ2947A1 (fr)	1998-11-25	2004-03-15	Chiesi Farma Spa	Inhalateur à compteur de dose sous pression.
US6004537A (en)	1998-12-18	1999-12-21	Baker Norton Pharmaceuticals, Inc.	Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
SE9900834D0 (sv)	1999-03-09	1999-03-09	Astra Ab	Novel combination

1997
- 1997-09-19 SE SE9703407A patent/SE9703407D0/xx unknown
1998
- 1998-09-09 DK DK02001670T patent/DK1210943T3/da active
- 1998-09-09 SK SK389-2000A patent/SK285330B6/sk not_active IP Right Cessation
- 1998-09-09 ES ES98944373T patent/ES2182357T3/es not_active Expired - Lifetime
- 1998-09-09 CZ CZ2000950A patent/CZ295250B6/cs not_active IP Right Cessation
- 1998-09-09 BR BR9812325-4A patent/BR9812325A/pt not_active Application Discontinuation
- 1998-09-09 HU HU0003848A patent/HUP0003848A2/hu not_active Application Discontinuation
- 1998-09-09 DE DE69807239T patent/DE69807239T2/de not_active Revoked
- 1998-09-09 EP EP02001670A patent/EP1210943B1/en not_active Revoked
- 1998-09-09 EP EP98944373A patent/EP1014993B1/en not_active Revoked
- 1998-09-09 PT PT98944373T patent/PT1014993E/pt unknown
- 1998-09-09 DE DE69834955T patent/DE69834955T2/de not_active Revoked
- 1998-09-09 JP JP2000512551A patent/JP2001517630A/ja active Pending
- 1998-09-09 AT AT02001670T patent/ATE329599T1/de not_active IP Right Cessation
- 1998-09-09 AU AU91928/98A patent/AU757235B2/en not_active Expired
- 1998-09-09 EE EEP200000145A patent/EE04297B1/xx unknown
- 1998-09-09 PL PL339295A patent/PL190782B1/pl unknown
- 1998-09-09 AT AT98944373T patent/ATE222106T1/de not_active IP Right Cessation
- 1998-09-09 KR KR1020007002900A patent/KR20010024140A/ko not_active Ceased
- 1998-09-09 TR TR2000/00726T patent/TR200000726T2/xx unknown
- 1998-09-09 UA UA2000031372A patent/UA72446C2/uk unknown
- 1998-09-09 SI SI9830272T patent/SI1014993T1/xx unknown
- 1998-09-09 PT PT02001670T patent/PT1210943E/pt unknown
- 1998-09-09 RU RU2000106597/14A patent/RU2199322C2/ru active
- 1998-09-09 IL IL13477398A patent/IL134773A/xx not_active IP Right Cessation
- 1998-09-09 ID IDW20000506A patent/ID24838A/id unknown
- 1998-09-09 WO PCT/SE1998/001599 patent/WO1999015182A1/en not_active Ceased
- 1998-09-09 SI SI9830844T patent/SI1210943T1/sl unknown
- 1998-09-09 MX MXPA00002615A patent/MXPA00002615A/es active IP Right Grant
- 1998-09-09 CA CA2302700A patent/CA2302700C/en not_active Expired - Lifetime
- 1998-09-09 DK DK98944373T patent/DK1014993T3/da active
- 1998-09-09 ES ES02001670T patent/ES2266322T3/es not_active Expired - Lifetime
- 1998-09-09 NZ NZ503173A patent/NZ503173A/en not_active IP Right Cessation
- 1998-09-09 CN CNB988093103A patent/CN1149998C/zh not_active Expired - Lifetime
- 1998-09-16 TW TW087115428A patent/TW546140B/zh not_active IP Right Cessation
- 1998-09-16 IN IN2781DE1998 patent/IN190791B/en unknown
- 1998-09-17 ZA ZA988516A patent/ZA988516B/xx unknown
- 1998-09-18 MY MYPI98004288A patent/MY127812A/en unknown
- 1998-09-18 AR ARP980104682A patent/AR013506A1/es unknown
- 1998-11-18 SA SA98190773A patent/SA98190773B1/ar unknown
2000
- 2000-03-15 IS IS5407A patent/IS2715B/is unknown
- 2000-03-17 NO NO20001401A patent/NO327176B1/no not_active IP Right Cessation
2001
- 2001-11-13 US US10/010,283 patent/US7897646B2/en not_active Expired - Fee Related
2002
- 2002-10-03 HK HK02107290.0A patent/HK1045812B/en not_active IP Right Cessation
2006
- 2006-09-12 CY CY20061101297T patent/CY1106156T1/el unknown
2010
- 2010-12-30 US US12/982,360 patent/US8461211B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ID24838A (id)	2000-08-24
CA2302700C (en)	2010-11-23
CZ2000950A3 (cs)	2000-06-14
EP1014993A1 (en)	2000-07-05
US8461211B2 (en)	2013-06-11
EP1210943A1 (en)	2002-06-05
ATE222106T1 (de)	2002-08-15
ZA988516B (en)	1999-03-19
MXPA00002615A (es)	2002-04-24
NZ503173A (en)	2001-08-31
CN1149998C (zh)	2004-05-19
ATE329599T1 (de)	2006-07-15
CZ295250B6 (cs)	2005-06-15
NO20001401L (no)	2000-03-17
HK1045812B (en)	2006-12-22
PL190782B1 (pl)	2006-01-31
DK1014993T3 (da)	2002-11-11
DE69834955D1 (de)	2006-07-27
NO327176B1 (no)	2009-05-04
EE200000145A (et)	2001-02-15
DK1210943T3 (da)	2006-09-18
EP1210943B1 (en)	2006-06-14
BR9812325A (pt)	2000-09-05
SE9703407D0 (sv)	1997-09-19
ES2182357T3 (es)	2003-03-01
PT1210943E (pt)	2006-09-29
KR20010024140A (ko)	2001-03-26
DE69834955T2 (de)	2007-01-25
IL134773A0 (en)	2001-04-30
CA2302700A1 (en)	1999-04-01
US20060189587A9 (en)	2006-08-24
IL134773A (en)	2005-03-20
MY127812A (en)	2006-12-29
IS2715B (is)	2011-02-15
SK285330B6 (sk)	2006-11-03
RU2199322C2 (ru)	2003-02-27
IN190791B (cs)	2003-08-23
SI1014993T1 (en)	2003-02-28
US20110097282A1 (en)	2011-04-28
NO20001401D0 (no)	2000-03-17
PL339295A1 (en)	2000-12-04
SI1210943T1 (sl)	2006-10-31
CN1271287A (zh)	2000-10-25
HUP0003848A2 (hu)	2001-08-28
AR013506A1 (es)	2000-12-27
SA98190773B1 (ar)	2006-10-02
ES2266322T3 (es)	2007-03-01
DE69807239D1 (de)	2002-09-19
IS5407A (is)	2000-03-15
TW546140B (en)	2003-08-11
JP2001517630A (ja)	2001-10-09
HK1045812A1 (en)	2002-12-13
DE69807239T2 (de)	2003-04-10
PT1014993E (pt)	2002-12-31
US7897646B2 (en)	2011-03-01
AU9192898A (en)	1999-04-12
SK3892000A3 (en)	2000-12-11
EP1014993B1 (en)	2002-08-14
US20020042404A1 (en)	2002-04-11
CY1106156T1 (el)	2011-06-08
UA72446C2 (uk)	2005-03-15
WO1999015182A1 (en)	1999-04-01
AU757235B2 (en)	2003-02-06
EE04297B1 (et)	2004-06-15

Publication	Publication Date	Title
TR200000726T2 (tr)	2000-09-21	Budesonid ve formoterol'ün yeni kullanımı.
KR970704430A (ko)	1997-09-06	전립선 질환, 자궁내막증 및 비만증의 치료를 위한 드롤록시펜의 용도(use of droloxifene for the treatment of prostatic diseases endometriosis and obesity)
DE69721766D1 (de)	2003-06-12	Neue arzneiformulierung
FI20115742L (fi)	2011-07-08	Mometasonifuroaatin käyttö lääkkeen valmistuksessa
ID27606A (id)	2001-04-12	Penghantaran raloksifen secara pulmonary dan nasal
HUP9802217A3 (en)	1999-09-28	Recombinant mva virus, and the use thereof
TR200002773T2 (tr)	2001-11-21	Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı.
ID23600A (id)	1995-11-30	Turunan tiazolidin dan oksazolidin, pembuatan dan penggunaannya untuk pengobatan (pecahan dari p-950453)
IT1307047B1 (it)	2001-10-23	Apparecchiatura per il trattamento umidificato dell'apnea da sonno.
IS5756A (is)	2000-12-08	Notkun hreinljósvirks (+) -norkisapríðs við meðhöndlun á öndunarstöðvun, lotugræðgi og öðrum meinum
TR28384A (tr)	1996-05-30	Flüoroalifatik -ve karboksil- iceren terminal gruplarina sahip polisilokzanlar, bunlarin hazirlanmasi, ve lifli malzemelerin muamelesinde kullanimlari.
ID30116A (id)	2001-11-08	Turunan-turunan piridopiranoazepin, pembuatannya dan penggunaan terapinya
AU2002308348A1 (en)	2003-04-10	Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours
DE69818664D1 (de)	2003-11-06	Nasal-applikator und abgabevorrichtung mit demselben
DE69324826D1 (de)	1999-06-10	Gegen Papillomaviren wirksame 2',5'-OLIGOADENYLAT-2',3'-CYCLOPHOSPHATE und 2',5'-OLIGOADENYLATE
FI970100L (fi)	1997-01-10	Muunnetun superantigeenin ja kohdetta etsivän yhdisteen välinen konjugaatti ja konjugaatin käyttö
EP0675120A3 (en)	1998-07-08	Use of ascorbyl-gamma-linolenate or a ascorbyl-dihomo-gamma-linolenate for the treatment of asthma, cancer, cardiovascular and inflammatory disorders
NO991619L (no)	1999-04-06	Anvendelse av en H+, K+-ATPase-inhibitor i behandlingen av nesepolypper
PL345325A1 (en)	2001-12-17	Use of optically pure (-) norcisapride in the treatment of apnea, bulimia, and other disorders
MD980129A (en)	2000-04-30	Antiherpetic remedy
FI965172A7 (fi)	1997-02-21	Uusia amido-kinoksaliinidioneja, niiden valmistus ja käyttö
BR0211533A (pt)	2004-07-13	Tratamento de dor crÈnica com 3-heterociclil- e 3-cicloalquil-3-ariloxipropanaminas
FR2728596B1 (fr)	1997-01-24	Degrilleur, notamment du type courbe
MANZAI	1997	The Home-cared Role of Physiatrists Who Work in Rehabilitation Center and Other Official Hospital
FI972637A0 (fi)	1997-06-19	K-ryhmän vitamiinin käyttö lisäkilpirauhasen liikatoiminnan hoitoon